elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38747405-F065A93C-ACBA-4585-8E8B-5B7F73AD9648
Q38747405-F065A93C-ACBA-4585-8E8B-5B7F73AD9648
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38747405-F065A93C-ACBA-4585-8E8B-5B7F73AD9648
Management of NAFLD: a stage-based approach.
P2860
Q38747405-F065A93C-ACBA-4585-8E8B-5B7F73AD9648
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38747405-F065A93C-ACBA-4585-8E8B-5B7F73AD9648
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a54cdd3adc5b94e18a3bdf73a0ad398a603a467
P2860
Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.